A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway

被引:0
作者
Ellen Busink
Dana Kendzia
Fatih Kircelli
Sophie Boeger
Jovana Petrovic
Helen Smethurst
Stephen Mitchell
Christian Apel
机构
[1] Fresenius Medical Care,Health Economics, Market Access & Political Affairs
[2] Fresenius Medical Care,Global Medical Information & Education
[3] Mtech Access Ltd,undefined
来源
The European Journal of Health Economics | 2023年 / 24卷
关键词
Systematic review; Renal replacement therapy; Patient pathway management; Patient choice; Economic evaluation; Healthcare policy; I110; I120;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:377 / 392
页数:15
相关论文
共 58 条
[11]  
Covic A(2013)The importance of residual renal function in peritoneal dialysis patients Adv Perit Dial 29 19-35
[12]  
Imbeault B(2018)Peritoneal dialysis-related peritonitis: challenges and solutions Int J Nephrol Renovasc Dis 11 173-2054358119871541
[13]  
Nadeau-Fredette AC(2008)Monitoring of the peritoneal membrane NDT Plus Clin Kidney 1 29-72
[14]  
Lambie M(2019)Cost controversies of a "Home Dialysis First" Policy Can J Kidney Health Dis. 6 2054358119871541-S313
[15]  
Davies SJ(2016)How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings? Health Res Policy Syst 14 21-283
[16]  
Diaz-Buxo JA(2007)Economic evaluation of palliative management versus peritoneal dialysis and haemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand Value in Health 10 61-677
[17]  
White SA(2001)The cost barrier to peritoneal dialysis in the developing world–an Asian perspective Perit Dial Int 21 S307-2048
[18]  
Himmele R(2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 372 275-2995
[19]  
Salzer WL(1996)Guidelines for authors and peer reviewers of economic submissions to the BMJ BMJ 313 42-132
[20]  
Struijk DG(2020)Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy BMC Nephrol 21 669-594